If you are an investor interested in connecting with an expert in a particular field or you are looking for licensable technologies to enhance your company’s products or services, contact a member of our team or search our database of available technologies.
Below are examples of two of the firms we're partnering with.
Universities and research institutions consistently generate intellectual property that has the potential to change how we live. However, many extraordinary inventions lay dormant because of the difficulties and even mysteries on how to bring these ideas to market. LGE Execs helps institutions commercialize technologies and products developed by professors and researchers from American and European universities.
LGE Execs brings demonstrated experience in the identification of potential market winners, capital fundraising, and development of a commercialization and go to market strategy. Once launched, LGE will help staff the new firm with interim and permanent executives and then bring the company through potential exit strategy options.
LGE can provide expertise in the following areas:
- Analysis of commercial viability
- Mentorship, advice and company leadership
- Financial resources
Founded in 1989, Emergent Technologies Inc. (ETI) is a unique life sciences venture capital firm that forms and manages companies and funds that license and commercialize groundbreaking institutional and university-based technologies. The firm is committed to bridging the gap between university or institutional technology transfer groups and companies in the life science industry, and acts as a commercialization partner both to the university and to industry.
ETI serves as a commercialization partner to the university or research institution technology transfer group by forging and leveraging strategic industry relationships that profit both the research institution and the industry. Throughout the commercialization process, ETI provides revenue to the university by way of sponsored research, grant writing, industrial collaboration, and ultimately royalties or other equity returns when a product reaches the market.
The numerous ways in which universities and research scientists can benefit from interacting with ETI include:
- Realization of the technology's impact on the public good
- Improve tenure track
- Increase collaboration with other world class scientists
- Expansion of lab, grant income and publications
- Financial reward, equity and share of income
The following are start-up entities developed by Emergent with TTUS technologies:
Auxano Biomedical, LLC is a biopharmaceutical company with a unique focus on wound healing - the reestablishment of tissues such as skin and the cornea.
Receptor Logic, Ltd. has developed an integrated diagnostic and therapeutic approach to be used in the design of customized anti-cancer and infectious disease treatments for individual patients.
Selenium, Ltd. is focused on the application of Selenium as an anti-bacterial agent and an anti-cellular, free radical chemistry technology.
We want to partner with you.
The RCFR team specializes in finding industry partners for further development of academic discovery and ultimately, technology commercialization.
Office of Research, Commercialization & Federal Relations
Texas Tech Plaza
Lubbock, TX 79409-2007
(806) 742.4102 fax
Browse technologies available for development opportunities. Go >